CI

MKT CAP:$73B

Cigna Corporation

Market Cap

$73B

Healthcare·Medical - Healthcare Plans·🇺🇸 United States·NYSE

Healthcare·Medical·🇺🇸·NYSE

Stock Price

$274.31-$4.81 (-1.73%)

Apr 24, 2026

Company Details

The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and ...

CEO

David Michael Cordani

IPO Date

Mar 31, 1982

Website

www.thecignagroup.com

Key Metrics TTM

Revenue

$196.5B

+55.0% YoY

Net Income

$8.9B

EPS (Diluted)

$26.98

Free Cash Flow

$11.9B

Revenue / Share

$732.71

Gross Margin

12.2%

Operating Margin

4.2%

Net Margin

4.6%

FCF Margin

6.1%

P/S

0.4x

P/E

8.2x

Earnings Reports

Q4 2025

Apr 30, 2026

PENDING

Q3 2025

Oct 30, 2025

$69.7BEPS $6.97

Q4 2022

Feb 23, 2023

$45.8BEPS $3.83

FY 2020

Feb 25, 2021

$160.4B+4.5%EPS $22.96

Q4 2020

Feb 25, 2021

$41.7BEPS $11.45

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 17	$10.4B	$3.6B	$3.6B
Q3 17	$10.5B	$3.7B	$3.7B
Q4 17	$10.4B	$3.2B	$3.9B
Q1 18	$11.4B	$4.1B	$1.3B
Q2 18	$11.5B	$4.0B	$1.2B
Q3 18	$11.5B	$4.1B	$1.1B
Q1 19	$37.9B	$6.3B	$2.2B
Q2 19	$38.8B	$6.3B	$2.2B
Q3 19	$38.6B	$6.3B	$2.1B
Q2 20	$39.3B	$6.5B	$2.6B
Q4 20	$41.7B	$5.8B	$1.3B
Q4 22	$45.8B	$5.7B	$1.7B
Q3 25	$69.7B	$5.9B	$2.6B

Valuation

Quarter	P/S	P/E
Q2 17	—	—
Q3 17	—	—
Q4 17	—	—
Q1 18	0.9x	15.6x
Q2 18	0.9x	16.1x
Q3 18	1.5x	23.9x
Q1 19	0.8x	15.8x
Q2 19	0.6x	13.7x
Q3 19	0.4x	11.5x
Q2 20	0.4x	11.7x
Q4 20	0.5x	8.4x
Q4 22	0.5x	10.6x
Q3 25	0.4x	8.5x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 17	$697M	$594M
Q3 17	$1.2B	$1.1B
Q4 17	$575M	$444M
Q1 18	$2.0B	$1.9B
Q2 18	$995M	$878M
Q3 18	$624M	$498M
Q1 19	$3.2B	$3.0B
Q2 19	$1.0B	$736M
Q3 19	$2.5B	$2.2B
Q2 20	$3.3B	$3.0B
Q4 20	$4.3B	$4.0B
Q4 22	$2.1B	$1.8B
Q3 25	$3.4B	$3.1B

Capital Expenditures

Quarter	CapEx
Q2 17	$103M
Q3 17	$146M
Q4 17	$131M
Q1 18	$103M
Q2 18	$117M
Q3 18	$126M
Q1 19	$194M
Q2 19	$303M
Q3 19	$243M
Q2 20	$256M
Q4 20	$319M
Q4 22	$345M
Q3 25	$278M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 18	+10.1%	+50.6%
Q3 18	+9.2%	+51.9%
Q1 19	+264.2%	+451.5%
Q2 19	+240.1%	+262.8%
Q3 19	+235.9%	+253.1%
Q2 20	+242.7%	+254.7%
Q4 20	+9.9%	+13.0%
Q4 22	+17.9%	+20.0%
Q3 25	+80.9%	+84.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 17	$0	0.0%
Q3 17	$0	0.0%
Q4 17	$0	0.0%
Q1 18	$0	0.0%
Q2 18	$0	0.0%
Q3 18	$0	0.0%
Q1 19	$0	0.0%
Q2 19	$0	0.0%
Q3 19	$0	0.0%
Q2 20	$0	0.0%
Q4 20	$0	0.0%
Q4 22	$0	0.0%
Q3 25	$0	0.0%

OpEx Breakdown

Quarter	G&A	SG&A
Q3 17	$612M	—
Q4 17	—	$10.0B
Q1 18	—	$2.7B
Q2 18	—	$2.7B
Q3 18	—	$2.9B
Q1 19	—	$3.2B
Q2 19	—	$3.2B
Q3 19	—	$3.3B
Q2 20	—	$3.3B
Q4 20	—	$3.8B
Q4 22	—	$3.5B
Q3 25	—	$3.4B

Revenue Segments

Quarter	Global Health Benefits Segment	Global Supplemental Benefits Segment	Group Disability And Life Segment	Other Operations Segment	Group Disability and Other	Health Services	Integrated Medical	International Markets	Cigna Healthcare	Evernorth
Q2 17	$8.1B	$955M	$1.1B	$118M	—	—	—	—	—	—
Q3 17	$8.1B	$985M	$1.1B	$115M	—	—	—	—	—	—
Q4 17	$8.3B	$1.0B	$1.1B	$119M	—	—	—	—	—	—
Q1 18	$9.1B	$1.1B	$1.1B	—	—	—	—	—	—	—
Q2 18	$9.2B	$1.1B	$1.1B	—	—	—	—	—	—	—
Q3 18	$9.1B	$1.1B	$1.1B	—	—	—	—	—	—	—
Q3 19	—	—	—	—	$1.3B	$24.9B	$9.1B	$1.4B	—	—
Q3 25	—	—	—	—	—	—	—	—	$10.9B	$60.4B

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$4.4B	$731M	$5.2B
Q2 22	$4.4B	$754M	$5.2B
Q3 22	$7.1B	$783M	$7.9B
Q4 22	$5.9B	$905M	$6.8B
Q1 23	$7.9B	$914M	$8.8B
Q2 23	$9.6B	$872M	$10.5B
Q3 23	$8.5B	$1.0B	$9.5B
Q4 23	$7.8B	$925M	$8.7B
Q1 24	$8.4B	$1.1B	$9.5B
Q2 24	$6.8B	$1.1B	$7.9B
Q3 24	$5.9B	$864M	$6.8B
Q4 24	$7.5B	$665M	$8.2B
Q1 25	$8.3B	$727M	$9.1B
Q2 25	$4.3B	$813M	$5.1B
Q3 25	$6.0B	$883M	$6.9B
Q4 25	$7.7B	$0	$7.7B

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 17	258M	—	—
Q3 17	253M	-1.8%	—
Q4 17	249M	-1.6%	—
Q1 18	246M	-1.4%	—
Q2 18	245M	-0.3%	-5.1%
Q3 18	243M	-1.0%	-4.3%
Q1 19	384M	+58.3%	+54.1%
Q2 19	378M	-1.6%	+53.8%
Q3 19	375M	-0.8%	+53.0%
Q2 20	367M	-2.0%	+51.5%
Q4 20	361M	-1.7%	-6.0%
Q4 22	305M	-15.4%	-19.2%
Q3 25	268M	-12.2%	-28.5%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 17	—	—
Q3 17	—	—
Q4 17	—	—
Q1 18	—	—
Q2 18	—	—
Q3 18	—	—
Q1 19	$514.2K	74K
Q2 19	$526.0K	74K
Q3 19	$522.4K	74K
Q2 20	$532.8K	74K
Q4 20	$566.0K	74K
Q4 22	$641.7K	71K
Q3 25	$949.0K	74K

Revenue / Employee